| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novartis AG (NVS) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. NVS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 117,140 | $1.05 | $122,683.42 | -0.8% | |
| Apr 10, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 200,746 | $1.07 | $214,247.11 | -1.3% | |
| Apr 5, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 130,594 | $0.99 | $129,244.90 | -0.8% | |
| Apr 2, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 231,763 | $0.94 | $218,685.93 | -1.4% | |
| Apr 1, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 127,150 | $1.86 | $236,258.00 | -3.0% | |
| Mar 28, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 317,346 | $0.99 | $313,286.03 | -1.9% | |
| Mar 15, 2019 | Novartis Bioventures Ltd | 10% Owner | Sell | 190,338 | $2.06 | $391,444.56 | -2.8% | |
| Aug 20, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 20,388 | $2.30 | $46,892.40 | -0.8% | |
| Aug 20, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 5,300 | $3.90 | $20,670.00 | - | |
| Aug 17, 2018 | Novartis Bioventures Ltd | 10% Owner | Sell | 17,508 | $2.10 | $36,766.80 | -0.4% |